Alembic Pharmaceuticals Limited (APLLTD.NS) NSE
725.50
+5.5(+0.76%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
725.50
+5.5(+0.76%)
Currency In INR
| Market Cap | 130.36B |
| Enterprise Value | 142.64B |
| P/E Ratio | 21.14 |
| PEG Ratio | 1.33 |
| Price/Sales Ratio | 1.94 |
| Price/Book Ratio | 2.51 |
| Enterprise/Revenue | 2.11 |
| Enterprise/EBITDA | 14.21 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.2 |
| Return On Assets | 0.08 |
| Return On Equity | 0.13 |
| Revenue | 73.45B |
| Revenue/Share | 373.59 |
| Gross Profit | 33.1B |
| EBITDA | 11.18B |
| Net Income | 6.75B |
| Diluted EPS | 34.33 |
| Total Cash | 2.03B |
| Total Cash/Share | 10.31 |
| Total Debt | 14.3B |
| Total Debt/Equity | 0.25 |
| Current Ratio | 1.76 |
| Book Value Per Share | 288.34 |
| 52-Week Change | -27.16 |
| 52-Week High | 1,107.9 |
| 52-Week Low | 635.8 |
| Moving Average 50 Days | 735.24 |
| Moving Average 200 Days | 826.19 |
| Average Volume | 126,999 |
| Shares Outstanding | 196.56M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 11 |
| Trailing Annual Dividend Yield | 1.52 |
| Payout Ratio | 0.32 |
| Last Split Factor | N/A |
| Last Split Date | N/A |